NIH reaffirms support for perinatal AZT despite cancer findings. National Institutes of Health.
Highleyman
L
L
D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission*; D006291:Health Policy; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011297:Prenatal Exposure Delayed Effects; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine